// App-Quantinova.ai

4805 : GLP-1(28–36) prevents ischemic cardiac injury by modulating metabolism and activating soluble adenylyl cyclase in coronary vascular cells

Researchers

Presenter

  • M.A. Siraj

Principal Investigators

  • D. Mundil

  • T. Afroze

  • L. Ying

  • M. Wheeler

  • G. Keller

  • M. Husain

Medical Centers

  • University of Toronto, Department of Cell & System Biology, Toronto, ON, Canada

  • University of Toronto, Department of Medical Biophysics, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • N/A

Biomarkers

  • Cyclic adenosine monophosphate

  • Cyclic AMP-dependent protein kinase

Drug/Treatment

  • Probenecid

  • Intranasal glucagon

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved